Paik K, Kim B, Youn S
Ann Dermatol. 2025; 37(1):32-38.
PMID: 39894671
PMC: 11791025.
DOI: 10.5021/ad.24.075.
Butacu A, Toma C, Negulet I, Manole I, Banica A, Plesea A
J Clin Med. 2025; 13(24.
PMID: 39768472
PMC: 11728371.
DOI: 10.3390/jcm13247549.
Yorulmaz A
Dermatol Pract Concept. 2024; 14(4).
PMID: 39652960
PMC: 11619982.
DOI: 10.5826/dpc.1404a227.
Horikawa H, Tanese K, Nonaka N, Seita J, Amagai M, Saito M
NPJ Syst Biol Appl. 2024; 10(1):130.
PMID: 39511184
PMC: 11544089.
DOI: 10.1038/s41540-024-00458-x.
Dauth S, Foldenauer A, Hallmann K, Kunz C, Konig A, Haferland I
Dermatology. 2024; 241(1):80-91.
PMID: 39504944
PMC: 11793098.
DOI: 10.1159/000542348.
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.
Campione E, Artosi F, Shumak R, Giunta A, Argenziano G, Assorgi C
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39459016
PMC: 11510175.
DOI: 10.3390/ph17101378.
Alitretinoin versus phototherapy as the first-line treatment in adults with severe chronic hand eczema: the ALPHA RCT.
Wittmann M, Smith I, Brown S, Berekmeri A, Vargas-Palacios A, Sunderland L
Health Technol Assess. 2024; 28(59):1-123.
PMID: 39364555
PMC: 11472215.
DOI: 10.3310/TWQC0141.
Nail Psoriasis: Clinical Features and Severity Assessment.
Youn S
Ann Dermatol. 2024; 36(4):191-196.
PMID: 39082654
PMC: 11291102.
DOI: 10.5021/ad.24.026.
Filling the "GAP" in Real-World Assessment of Psoriatic Arthritis Disease Activity: Performance Characteristics of a Global/Pain Composite Endpoint.
Tillett W, Birt J, Vadhariya A, Ross S, Ngantcha M, Ng K
Rheumatol Ther. 2024; 11(5):1101-1114.
PMID: 38955921
PMC: 11422320.
DOI: 10.1007/s40744-024-00690-1.
Long-pulsed nd: YAG laser treatment of nail psoriasis: clinical and ultrasonographic assessment.
El-Basiony M, El-Komy M, Samy N, Aly D, El-Gendy H, Abdel Salam Hassan M
Arch Dermatol Res. 2024; 316(7):365.
PMID: 38850336
PMC: 11162362.
DOI: 10.1007/s00403-024-03036-7.
The Promising Role of Artificial Intelligence in Nail Diseases.
Solak S, Goktay F
Balkan Med J. 2024; 41(4):234-235.
PMID: 38767411
PMC: 11588894.
DOI: 10.4274/balkanmedj.galenos.2024.2024-010424.
Safety and effectiveness of guselkumab in Japanese patients with psoriasis: 20-week interim analysis of a postmarketing surveillance study.
Tada Y, Sugiura Y, Kamishima M, Tanaka Y, Tsuchiya H, Masuda J
J Dermatol. 2024; 51(6):779-790.
PMID: 38747075
PMC: 11484128.
DOI: 10.1111/1346-8138.17255.
Telemedicine in Nail Psoriasis: Validation of a New Tool to Monitor (In-Person, In-Picture, and In-Video) Nail Psoriasis Severity in Patients with Concurrent Onychophagia and Onychotillomania.
Pacifico A, Iorizzo M, Pasch M, Kridin K, Fabbro M, Mercuri S
Dermatol Ther (Heidelb). 2024; 14(5):1161-1172.
PMID: 38700647
PMC: 11116310.
DOI: 10.1007/s13555-024-01160-w.
Effectiveness, safety and impact of guselkumab on sexuality and perceived stigmatization in patients with psoriasis in routine clinical practice: Week 28 results from the prospective German multicentre G-EPOSS study.
Gerdes S, Ostendorf R, Suss A, Schadeck T, Taut F, Makuc J
J Eur Acad Dermatol Venereol. 2024; 39 Suppl 1:15-26.
PMID: 38602225
PMC: 11862875.
DOI: 10.1111/jdv.19927.
Triamcinolone Acetonide Injections in Nail Psoriasis: A Pragmatic Analysis.
Grover C, Kharghoria G, Bansal S
Skin Appendage Disord. 2024; 10(1):50-59.
PMID: 38313569
PMC: 10836911.
DOI: 10.1159/000534699.
Ultrasonography Enthesitis and Synovitis Screening in Psoriatic Patients: A Case Control Study.
Boussaid S, Ben Aissa R, Rekik S, Rahmouni S, Jammali S, Zouaoui K
Mediterr J Rheumatol. 2024; 34(4):495-505.
PMID: 38282930
PMC: 10815525.
DOI: 10.31138/mjr.180923.ues.
Radiological progression and predictive factors in psoriatic arthritis: insights from a decade-long retrospective cohort study.
Ozdemir Isik O, Gokcen N, Temiz Karadag D, Yazici A, Cefle A
Clin Rheumatol. 2023; 43(1):259-267.
PMID: 38044416
DOI: 10.1007/s10067-023-06839-7.
Efficacy of Guselkumab in Treating Nails, Scalp, Hands, and Feet in Patients with Psoriasis and Self-reported Psoriatic Arthritis.
Orbai A, Chakravarty S, You Y, Shawi M, Yang Y, Merola J
Dermatol Ther (Heidelb). 2023; 13(11):2859-2868.
PMID: 37713133
PMC: 10613182.
DOI: 10.1007/s13555-023-01012-z.
Assessment and Monitoring of Nail Psoriasis with Ultra-High Frequency Ultrasound: Preliminary Results.
Michelucci A, Dini V, Salvia G, Granieri G, Manzo Margiotta F, Panduri S
Diagnostics (Basel). 2023; 13(16).
PMID: 37627974
PMC: 10453049.
DOI: 10.3390/diagnostics13162716.
Disease Assessment in Psoriasis.
Manchanda Y, De A, Das S, Chakraborty D
Indian J Dermatol. 2023; 68(3):278-281.
PMID: 37529444
PMC: 10389140.
DOI: 10.4103/ijd.ijd_420_23.
